Archives202520242023202220212020201920182017201620152014201320122011 August 31, 2022Exercise of Options Read More August 24, 2022Exercise of Options Read More August 18, 2022Lanstead Capital TR1 Read More August 16, 2022Total Voting Rights Read More August 11, 2022Result of Broker Option / PDMR Dealings Read More August 04, 2022INVESTOR PRESENTATION Via Investor Meet Company Platform | 12 midday (BST) | 4 August 2022 Read More August 03, 2022Subscription and Placing to raise £1.1 million; Sharing Agreement; to progress product portfolio. Broker Option to raise up to £1.3m Read More July 07, 2022Initiation of research Read More June 28, 20222022 Result of ANNUAL GENERAL MEETING – all resolutions passed Read More June 27, 2022Avion seeks final regulatory guidance as it prepares for the start of the international Phase 3 trial of Lupuzor™ in Lupus patients Read More June 21, 2022Lanstead Capital Investors LP share holding update Read More June 11, 2022FDA confirms response date for Type C Meeting as 29th August 2022 Read More 1…56789…24
August 04, 2022INVESTOR PRESENTATION Via Investor Meet Company Platform | 12 midday (BST) | 4 August 2022 Read More
August 03, 2022Subscription and Placing to raise £1.1 million; Sharing Agreement; to progress product portfolio. Broker Option to raise up to £1.3m Read More
June 27, 2022Avion seeks final regulatory guidance as it prepares for the start of the international Phase 3 trial of Lupuzor™ in Lupus patients Read More
